Exact Mass: 499.11732900000004
Exact Mass Matches: 499.11732900000004
Found 70 metabolites which its exact mass value is equals to given mass value 499.11732900000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Halofantrine
Halofantrine is a drug used to treat malaria. It belongs to the phenanthrene class of compounds that includes quinine and lumefantrine. It appears to inhibit polymerisation of heme molecules (by the parasite enzyme heme polymerase), resulting in the parasite being poisoned by its own waste. Halofantrine has been shown to preferentially block open and inactivated HERG channels leading to some degree of cardiotoxicity. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
VX-11e
VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki < 2 nM.
CDK9 inhibitor
C26H21N5O4S (499.1314186000001)
Glucose lactate pyruvate glutamate
C17H25NO16 (499.11732900000004)
Palygorskite
It is used in foods as a clarifying and flocculating agent [DFC]
Cys Cys Phe Gln
Cys Cys Gln Phe
Cys Phe Cys Gln
Cys Phe Gln Cys
Cys Gln Cys Phe
Cys Gln Phe Cys
Asp Asp His Asn
Asp Asp Asn His
Asp His Asp Asn
Asp His Asn Asp
Asp Asn Asp His
Asp Asn His Asp
Phe Cys Cys Gln
Phe Cys Gln Cys
Phe Gln Cys Cys
His Asp Asp Asn
His Asp Asn Asp
His Asn Asp Asp
Asn Asp Asp His
Asn Asp His Asp
Asn His Asp Asp
Gln Cys Cys Phe
Gln Cys Phe Cys
Gln Phe Cys Cys
3-[(4-Methyl-3,5-dinitrophenyl)sulfonyl]-2-(2,4,5-trimethoxypheny l)-1,3-thiazolidine
C19H21N3O9S2 (499.07191760000006)
Fosquidone
C28H22NO6P (499.11846820000005)
C274 - Antineoplastic Agent > C177298 - Mitochondrial Targeting Antineoplastic Agent C26170 - Protective Agent > C275 - Antioxidant
4-nitrobenzyl [2R-(2alpha,5beta,6alpha,7beta)]-3-methylene-8-oxo-7-(phenoxyacetamido)-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylate 5-oxide
C23H21N3O8S (499.10493060000005)
N-[4-(aminocarbonyl)phenyl]-4-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azo]benzamide
C25H21N7O5 (499.16040960000004)
Sodelglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
Pivampicillin hydrochloride
C22H30ClN3O6S (499.1543750000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-[(2-isopropyl-3-oxo-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)thio]acetamide
n-[4-[[Glutamic acid]-carbonyl]-benzene-sulfonyl-d-prolinyl]-3-amino-propanoic acid
C20H25N3O10S (499.12605900000005)
3-(5-Amino-7-hydroxy-[1,2,3]triazolo[4,5-D]pyrimidin-2-YL)-N-[2-(2-(hydroxymethyl-phenylsulfanyl)-benzyl]-benzamide
(2R)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate
(2S)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate
5-O-(2-hydroxypropanoyl) 1-O-(2-oxopropanoyl) 2-amino-2-[2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]pentanediperoxoate
C17H25NO16 (499.11732900000004)
(2S)-2-[3-[3-(trifluoromethyl)-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
C22H19F6N5O2 (499.14428660000004)
N-(1,3-benzodioxol-5-ylmethyl)-1-ethyl-6-(4-morpholinylsulfonyl)-4-oxo-3-quinolinecarboxamide
[4-(2-Chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone
C24H22ClN3O5S (499.0968632000001)
3-[[2-[[5-[(4-Cyanophenoxy)methyl]-4-phenyl-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]benzoic acid methyl ester
C26H21N5O4S (499.1314186000001)
8-chloro-1-methyl-2,6-dioxo-7H-purine-3-carboxylic acid 2-(diphenylmethyl)oxy-N,N-dimethylethanamine
C24H26ClN5O5 (499.1622376000001)
4-(4-Chlorobenzoyl)-1-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-5-phenylpyrrolidine-2,3-dione
C28H22ClN3O4 (499.12987620000007)
(2R)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid
(2S)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid
Halofantrine
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
nocardicin A(1-)
An alpha-amino-acid anion that is the conjugate base of nocardicin A, arising from deprotonation of the carboxy groups and protonation of the amino group.
isonocardicin A(1-)
Conjugate base of isonocardicin A zwitterion where both carboxy groups are deprotonated while the homoserine amino group is protonated.
RMC-0331
C22H25ClF3N5O3 (499.15979260000006)
RMC-0331 (RM-023) is a potent, selective and orally bioavailable SOS1 inhibitor. RMC-0331 is an in vivo tool compound that blocks RAS activation via disruption of the RAS-SOS1 interaction[1].